Dalal Street Investment Journal | DSIJ Article Detail

[email protected] |+91 9228821920

The stock of this Pharma Company Hits 20 per cent Upper Circuit with High Intraday Volumes; FIIs Increased their Stake in Q2 FY25 — Read More

The stock of this Pharma Company Hits 20 per cent Upper Circuit with High I...

DSIJ Intelligence
03 Dec 2024

This Pharma Company Reports 25 per cent Profit Growth: Aiming for Rs 750 Crore Revenue by FY26, Promoter and FIIs Increased their Stake — Read More

This Pharma Company Reports 25 per cent Profit Growth: Aiming for Rs 750 Cr...

DSIJ Intelligence
08 Aug 2024

In conversation with Mahendra Patel, Managing Director of Lincoln Pharmaceuticals Ltd — Read More

In conversation with Mahendra Patel, Managing Director of Lincoln Pharmaceu...

We anticipate stronger growth through our upcoming product launches in domestic and export markets, ...

DSIJ Intelligence
12 Mar 2024

Copyright 2025 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)